Aligos Therapeutics Inc (ALGS)

Aligos Therapeutics Inc (ALGS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $33.3M; returns 1 day -0.8%, 1 week -1.6%, 1 year -49.6%.

Aligos Therapeutics is a clinical-stage biopharmaceutical company focused on developing a pipeline of small molecule and oligonucleotide therapeutics for viral and liver diseases.

Groups ALGS belongs to

• Clinical Stage Biotech
• Biotechnology
• Healthcare
• Metabolic Disorders
• Liver Disease
• Biopharmaceutical
• Infectious Diseases
• Antivirals
• Clinical Stage

ALGS financial model: income statement, cash flow and balance sheet